Drugplain

Acyclovir Sodium 1000 mg/20mL

Acyclovir Sodium · INJECTION, SOLUTION · AuroMedics Pharma LLC

6 Recalls on Record
Plain English

Acyclovir Sodium is an antiviral medication given by injection into the vein to treat serious herpes infections, including herpes simplex virus and varicella-zoster virus infections. This medication works by slowing the growth and spread of the virus in your body.

Key Facts

Brand Name
Acyclovir Sodium
Generic Name
Acyclovir Sodium
NDC Code (Product)
55150-155
Manufacturer
AuroMedics Pharma LLC
Strength
1000 mg/20mL
Dosage Form
INJECTION, SOLUTION
Route
INTRAVENOUS
Marketing Status
Application #
ANDA203701
Marketing Start
10/11/2013

Recall History

6 Recalls on Record
Class I02/18/2021

Zydus Pharmaceuticals (USA) Inc

Crystallization: customer complaints for crystallization in finished product.

TerminatedVoluntary: Firm initiated
Class II12/28/2022

Eugia US LLC

Presence of Particulate Matter: Customer complaint of dark particles found inside the vial

OngoingVoluntary: Firm initiated
Class II11/14/2014

Attix Pharmaceuticals

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

TerminatedVoluntary: Firm initiated
Class II02/05/2026

Fresenius Kabi Compounding, LLC

Lack of Assurance of Sterility

OngoingVoluntary: Firm initiated
Class I02/18/2021

Zydus Pharmaceuticals (USA) Inc

Crystallization: customer complaints for crystallization in finished product.

TerminatedVoluntary: Firm initiated
Class II09/26/2022

AuroMedics Pharma LLC

Presence of Particulate Matter: Customer complaint for a dark red, brown and black particulate floating inside vial.

CompletedVoluntary: Firm initiated

Side Effects Reported to FDA

FDA FAERS database · These are reported events, not confirmed side effects

drug ineffective112 reports
dyspnoea108 reports
headache106 reports
pyrexia88 reports
nausea83 reports
hypertension80 reports
asthma75 reports
fatigue75 reports
off label use75 reports
therapeutic product effect incomplete73 reports

Full Prescribing Information

Source: FDA Drug Label (SPL)For healthcare professionals

Indications & Usage

INDICATIONS AND USAGE Herpes Simplex Infections in Immunocompromised Patients Acyclovir Sodium Injection is indicated for the treatment of initial and recurrent mucosal and cutaneous herpes simplex (HSV-1 and HSV-2) in immunocompromised patients. Initial Episodes of Herpes Genitalis Acyclovir Sodium Injection is indicated for the treatment of severe initial clinical episodes of herpes genitalis in immuno-competent patients. Herpes Simplex Encephalitis Acyclovir Sodium Injection is indicated for the treatment of herpes simplex encephalitis. Neonatal Herpes Simplex Virus Infection Acyclovir Sodium Injection is indicated for the treatment of neonatal herpes infections. Varicella-Zoster Infections in Immunocompromised Patients Acyclovir Sodium Injection is indicated for the treatment of varicella-zoster (shingles) infections in immunocompromised patients.

Dosage & Administration

DOSAGE AND ADMINISTRATION CAUTION - RAPID OR BOLUS INTRAVENOUS INJECTION MUST BE AVOIDED (see WARNINGS and PRECAUTIONS ). INTRAMUSCULAR OR SUBCUTANEOUS INJECTION MUST BE AVOIDED (see WARNINGS ). Therapy should be initiated as early as possible following onset of signs and symptoms of herpes infections. A maximum dose equivalent to 20 mg/kg every 8 hours should not be exceeded for any patient. Dosage HERPES SIMPLEX INFECTIONS MUCOSAL AND CUTANEOUS HERPES SIMPLEX (HSV-1 AND HSV-2) INFECTIONS IN IMMUNOCOMPROMISED PATIENTS Adults and Adolescents (12 years of age and older) 5 mg/kg infused at a constant rate over 1 hour, every 8 hours for 7 days. Pediatrics (Under 12 years of age) 10 mg/kg infused at a constant rate over 1 hour, every 8 hours for 7 days. SEVERE INITIAL CLINICAL EPISODES OF HERPES GENITALIS Adults and Adolescents (12 years of age and older) 5 mg/kg infused at a constant rate over 1 hour, every 8 hours for 5 days. HERPES SIMPLEX ENCEPHALITIS Adults and Adolescents (12 years of age and older) 10 mg/kg infused at a constant rate over 1 hour, every 8 hours for 10 days. Pediatrics (3 months to 12 years of age) 20 mg/kg infused at a constant rate over 1 hour, every 8 hours for

Warnings

WARNINGS Acyclovir Sodium Injection is intended for intravenous infusion only, and should not be administered topically, intramuscularly, orally, subcutaneously, or in the eye. Intravenous infusions must be given over a period of at least 1 hour to reduce the risk of renal tubular damage (see PRECAUTIONS and DOSAGE AND ADMINISTRATION ). Renal failure, in some cases resulting in death, has been observed with acyclovir therapy (see ADVERSE REACTIONS, Observed During Clinical Practice and OVERDOSAGE ). Thrombotic thrombocytopenic purpura/hemolytic uremic syndrome (TTP/HUS), which has resulted in death, has occurred in immunocompromised patients receiving acyclovir therapy.

Contraindications

CONTRAINDICATIONS Acyclovir Sodium Injection is contraindicated for patients who develop hypersensitivity to acyclovir or valacyclovir.

Drug Interactions

Drug Interactions See CLINICAL PHARMACOLOGY, Pharmacokinetics .

Adverse Reactions

ADVERSE REACTIONS The adverse reactions listed below have been observed in controlled and uncontrolled clinical trials in approximately 700 patients who received acyclovir at approximately 5 mg/kg (250 mg/m 2 ) 3 times daily, and approximately 300 patients who received approximately 10 mg/kg (500 mg/m 2 ) 3 times daily. The most frequent adverse reactions reported during administration of acyclovir were inflammation or phlebitis at the injection site in approximately 9% of the patients, and transient elevations of serum creatinine or BUN in 5% to 10% (the higher incidence occurred usually following rapid [less than 10 minutes] intravenous infusion). Nausea and/or vomiting occurred in approximately 7% of the patients (the majority occurring in nonhospitalized patients who received 10 mg/kg). Itching, rash, or hives occurred in approximately 2% of patients. Elevation of transaminases occurred in 1% to 2% of patients. The following hematologic abnormalities occurred at a frequency of less than 1%: anemia, neutropenia, thrombocytopenia, thrombocytosis, leukocytosis, and neutrophilia. In addition, anorexia and hematuria were observed. Observed During Clinical Practice In addition to adv

Frequently Asked Questions

What is Acyclovir Sodium used for?

Acyclovir Sodium is an antiviral medication given by injection into the vein to treat serious herpes infections, including herpes simplex virus and varicella-zoster virus infections. This medication works by slowing the growth and spread of the virus in your body.

Is Acyclovir Sodium a controlled substance?

Acyclovir Sodium is not classified as a controlled substance by the DEA.

What is the generic name for Acyclovir Sodium?

The generic name for Acyclovir Sodium is Acyclovir Sodium. There are no other listed brand versions of Acyclovir Sodium.

What is the NDC code for Acyclovir Sodium 1000 mg/20mL?

The NDC (National Drug Code) for Acyclovir Sodium 1000 mg/20mL is 55150-155, listed by AuroMedics Pharma LLC.

Product NDC

55150-155

Package NDC

55150-155-21

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)